Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 3 studies | 20% ± 2% | |
glutamatergic neuron | 3 studies | 33% ± 16% | |
oligodendrocyte | 3 studies | 20% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 31% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 7837.82 | 245 / 245 | 100% | 21.09 | 500 / 502 |
brain | 70% | 2478.44 | 1844 / 2642 | 56% | 10.53 | 396 / 705 |
kidney | 78% | 3593.56 | 69 / 89 | 46% | 5.58 | 413 / 901 |
bladder | 67% | 5600.86 | 14 / 21 | 53% | 8.76 | 269 / 504 |
liver | 71% | 2080.83 | 161 / 226 | 48% | 4.35 | 196 / 406 |
esophagus | 66% | 4762.15 | 952 / 1445 | 51% | 6.09 | 93 / 183 |
lung | 68% | 4751.76 | 395 / 578 | 48% | 6.76 | 552 / 1155 |
skin | 67% | 2938.05 | 1208 / 1809 | 49% | 8.84 | 231 / 472 |
pancreas | 63% | 3390.59 | 207 / 328 | 52% | 7.83 | 93 / 178 |
intestine | 64% | 5835.53 | 619 / 966 | 46% | 5.31 | 244 / 527 |
stomach | 64% | 3862.96 | 228 / 359 | 39% | 4.21 | 112 / 286 |
ureter | 0% | 0 | 0 / 0 | 100% | 10.43 | 1 / 1 |
thymus | 66% | 5686.73 | 434 / 653 | 30% | 7.66 | 180 / 605 |
adrenal gland | 61% | 8255.31 | 158 / 258 | 35% | 5.84 | 80 / 230 |
tonsil | 0% | 0 | 0 / 0 | 71% | 11.17 | 32 / 45 |
adipose | 68% | 4406.31 | 816 / 1204 | 0% | 0 | 0 / 0 |
heart | 68% | 2607.99 | 583 / 861 | 0% | 0 | 0 / 0 |
muscle | 67% | 2328.55 | 542 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 66% | 4605.37 | 879 / 1335 | 0% | 0 | 0 / 0 |
breast | 63% | 3702.72 | 291 / 459 | 1% | 0.18 | 10 / 1118 |
spleen | 64% | 8523.98 | 154 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 62% | 2200.42 | 574 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 38% | 7.28 | 11 / 29 |
eye | 0% | 0 | 0 / 0 | 33% | 4.49 | 26 / 80 |
uterus | 0% | 0 | 0 / 170 | 7% | 1.11 | 32 / 459 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ovary | 0% | 0 | 0 / 180 | 0% | 0 | 0 / 430 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0060765 | Biological process | regulation of androgen receptor signaling pathway |
GO_0006338 | Biological process | chromatin remodeling |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0002457 | Biological process | T cell antigen processing and presentation |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0001650 | Cellular component | fibrillar center |
GO_0005634 | Cellular component | nucleus |
GO_0032453 | Molecular function | histone H3K4 demethylase activity |
GO_0003677 | Molecular function | DNA binding |
GO_0032452 | Molecular function | histone demethylase activity |
GO_0050681 | Molecular function | nuclear androgen receptor binding |
GO_0034647 | Molecular function | histone H3K4me/H3K4me2/H3K4me3 demethylase activity |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | KDM5D |
Protein name | [histone H3]-trimethyl-L-lysine(4) demethylase (EC 1.14.11.67) Lysine demethylase 5D Lysine-specific demethylase 5D (EC 1.14.11.67) (Histocompatibility Y antigen) (H-Y) (Histone demethylase JARID1D) (Jumonji/ARID domain-containing protein 1D) (Protein SmcY) ([histone H3]-trimethyl-L-lysine(4) demethylase 5D) |
Synonyms | HYA SMCY HY JARID1D KIAA0234 |
Description | FUNCTION: Histone demethylase that specifically demethylates 'Lys-4' of histone H3, thereby playing a central role in histone code. Does not demethylate histone H3 'Lys-9', H3 'Lys-27', H3 'Lys-36', H3 'Lys-79' or H4 'Lys-20'. Demethylates trimethylated and dimethylated but not monomethylated H3 'Lys-4'. May play a role in spermatogenesis. Involved in transcriptional repression of diverse metastasis-associated genes; in this function seems to cooperate with ZMYND8. Suppresses prostate cancer cell invasion. Regulates androgen receptor (AR) transcriptional activity by demethylating H3K4me3 active transcription marks. . |
Accessions | Q9BY66 ENST00000447300.1 ENST00000541639.5 [Q9BY66-3] ENST00000440077.5 H7BZF9 ENST00000415360.1 ENST00000317961.9 [Q9BY66-1] ENST00000382806.6 [Q9BY66-2] E9PFH2 C9JGA3 |